Skip to main content
. 2013 Oct 22;13:276. doi: 10.1186/1472-6882-13-276

Table 4.

Effect of SCEE treatment on different liver markers

Group LDH (U/L) Billirubin (mg/ml) ALT (U/L) AST (U/L) ALP (U/L) γ –GT (U/L)
Control
1847±21.2e
0.33±0.1b
22.67±1.5b
38.7±3.5d
56.0±1.0cd
0.937±0.0de
Oil+DMSO
1964±30.2cd
0.33±0.1b
21±1.00bc
40.3±1.5cd
54.0±1.0d
0.863±0.0e
CCl4 (1 ml/kg)
3268±55.7a
0.90±1.0a
43.3±1.5a
70.0±3.0a
91.3±2.5a
2.58±0.21a
Silymarin (200 mg/kg)+CCl4
1753±15.3f
0.37±0.1b
18.0±1.0a
44.7±2.5cd
60.3±2.5c
1.16±0.10cd
SCEE (150 mg/kg)+CCl4
2207±21.4b
0.43±0.1b
20.0±1.0bc
56.3±3.1b
71.3±1.5b
1.77±0.20b
SCEE (300 mg/kg)+CCl4
2054±48.0c
0.43±0.1b
20.5±0.5bc
47.0±2.6c
69.0±1.0b
1.35±0.17c
SCEE (300 mg/kg) 1902±20.4d 0.33±0.1b 22.0±1.0b 40.7±2.5cd 58.7±1.5cd 1.04±0.10de

Values are expressed as mean±SD (N=3). Values within the same column with different superscripts letters are significantly (P<0.05) different. (SCHE); n-hexane fraction, (SCEE); ethyl acetate fraction, (SCBE); n-butanol fraction, (SCAE), aqueous fraction.